# US 2021/0340509 A1 · Reverse transcriptase with increased enzyme activity and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0340509 A1
- Document ID: US20210340509A1
- Status: Published application
- Kind: A1
- Application number: 17/358,856
- Filed: 2021-06-25
- Published: 2021-11-04
- Earliest claimed: 2018-12-26
- Assignees: Bgi Shenzhen
- Applicants: Bgi Shenzhen
- Inventors: Huanhuan Liu; Na Guo; Huizhen Li; Zhougang Zhang; Hongyan Han; Miaomiao Guo; Yue Zheng; Yuliang Dong; Wenwei Zhang; Chongjun Xu
- Web page: https://patentgrep.com/patent/US20210340509A1

## CPC

- C12N 9/1276: {RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase}
- C12N 9/12: transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Y 207/07049: RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES

## Abstract

The present disclosure relates to a reverse transcriptase and an application thereof. The reverse transcriptase has mutation sites such as R450H compared with the wild-type M-MLV reverse transcriptase. The reverse transcriptase has increased polymerase activity, improved thermal stability, and reduced RNase H activity.

## Claims

### Claim 1

A reverse transcriptase, comprising amino acid mutations at positions 302 and 524 compared to the amino acid sequence of SEQ ID NO: 2 of a wild-type M-MLV reverse transcriptase.

### Claim 2 (depends on 1)

The reverse transcriptase according to claim 1, wherein the reverse transcriptase further comprises at least one of amino acid mutations at positions 286, 313, 330, 435, 562 and 583, compared to the amino acid sequence of SEQ ID NO: 2.

### Claim 3 (depends on 1)

The reverse transcriptase according to claim 1, wherein the amino acid mutations comprises:
substitution of Glutamicacid at positions 302 with Lysine, and
substitution of Asparticacid at positions 524 with Alanine.

### Claim 4 (depends on 2)

The reverse transcriptase according to claim 2, wherein the at least one of amino acid mutations at positions 286, 313, 330, 435, 562 and 583 comprises:
substitution of E at position 286 with K,
substitution of W at position 313 with F,
substitution of T at position 330 with P,
substitution of L at position 435 with R or G,
substitution of E at position 562 with Q, and
substitution of D at position 583 with G.

### Claim 5 (depends on 1)

The reverse transcriptase according to claim 1, comprising at least one of mutations from E286K-E302K-W313F-D524A-D583G, E302K-D524A, E302K-L435R-D524A, E302K-L435R-D524A-E562Q, E302K-L435G-D524A, E286K-E302K-W313F-T330P-D524A-D583G, and E286K-E302K-D524A, compared to the amino acid sequence of SEQ ID NO: 2.

### Claim 6 (depends on 1)

The reverse transcriptase according to claim 1, wherein the reverse transcriptase has increased polymerase activity, increased thermal stability and decreased RNase H activity.

### Claim 7 (depends on 1)

The reverse transcriptase according to claim 1, wherein a polymerase activity of the reverse transcriptase is at least 1 to 4 times higher than that of the wild-type M-MLV reverse transcriptase.

### Claim 8 (depends on 1)

The reverse transcriptase according to claim 1, wherein an RNase H activity of the reverse transcriptase is reduced by 30% to 80% compared to that of the wild-type M-MLV reverse transcriptase.

### Claim 9 (depends on 1)

The reverse transcriptase according to claim 1, wherein the reverse transcriptase keeps its reverse transcriptase activity unchanged after being heated at 50° C. for 30 minutes, or wherein the reverse transcriptase keeps its reverse transcriptase activity unchanged after being heated at 42° C. for 30 minutes.

### Claim 10 (depends on 1)

An isolated nucleic acid molecule encoding the reverse transcriptase of claim 1.

### Claim 11 (depends on 10)

A construct comprising the isolated nucleic acid molecule of claim 10,
preferably the isolated nucleic acid molecule is operably linked to a promoter,
wherein the promoter is one selected from λ-PL promoter, tac promoter, trp promoter, araBAD promoter, T7 promoter and trc promoter.

### Claim 12 (depends on 11)

A host cell comprising the construct of claim 11.

### Claim 13 (depends on 1)

A method for producing a reverse transcriptase of claim 1, comprising:
culturing a host cell, wherein the host cell comprises a construct comprising the isolated nucleic acid molecule encoding the reverse transcriptase,
preferably the isolated nucleic acid molecule is operably linked to a promoter,
wherein the promoter is one selected from λ-PL promoter, tac promoter, trp promoter, araBAD promoter, T7 promoter and trc promoter,
inducing the host cell to express the reverse transcriptase, and
isolating the reverse transcriptase,
preferably the host cell is Escherichia coli.

### Claim 14 (depends on 1)

A kit comprising the reverse transcriptase of claim 1,
preferably the kit further comprises at least one from one or more nucleotides, one or more DNA polymerases, one or more buffers, one or more primers, and one or more terminators,
wherein the terminator is dideoxynucleotide.

### Claim 15 (depends on 1)

A method for reverse transcription of nucleic acid molecules, comprising:
mixing at least one nucleic acid template with at least one reverse transcriptase to obtain a mixture, wherein the reverse transcriptase is the reverse transcriptase of claim 1,
subjecting the mixture to a reverse transcription reaction to obtain a first nucleic acid molecule, wherein the first nucleic acid molecule is completely or partially complementary to the at least one nucleic acid template,
wherein the first nucleic acid molecule is a cDNA molecule,
wherein the nucleic acid template is mRNA,
preferably wherein an amount of the nucleic acid template is at least 10 pg.

### Claim 16 (depends on 15)

The method according to claim 15, further comprising:
subjecting the first nucleic acid molecule to a PCR reaction, to obtain a second nucleic acid molecule,
wherein the second nucleic acid molecule is completely or partially complementary to the first nucleic acid molecule.

### Claim 17 (depends on 1)

A method for amplifying nucleic acid molecules, comprising:
subjecting at least one nucleic acid template and at least one reverse transcriptase to a first mixing reaction, to obtain a reaction product, wherein the at least one reverse transcriptase is the reverse transcriptase of claim 1,
subjecting the reaction product and at least one DNA polymerase to a second mixing reaction, to obtain an amplified nucleic acid molecule, wherein the amplified nucleic acid molecule is completely or partially complementary to the at least one nucleic acid template.

### Claim 18 (depends on 17)

The method according to claim 17, further comprising:
sequencing the amplified nucleic acid molecule to determine a nucleotide sequence of the amplified nucleic acid molecule.

### Claim 19 (depends on 15)

A method for constructing a cDNA library, comprising:
subjecting a biological sample to be tested to RNA extraction, to obtain mRNA of the biological sample to be tested,
treating the mRNA of the biological sample to be tested by the method of claim 15, to obtain cDNA molecules, and
subjecting the cDNA molecules to amplification and library construction to obtain a cDNA library.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the biological sample to be tested is an animal tissue, a plant tissue or bacteria,
preferably wherein a total RNA content in the biological sample to be tested is at least 10 pg,
preferably wherein the biological sample to be tested is at least one selected from soil, feces, blood and serum,
preferably wherein a length of obtained cDNA is at least 2000 bp.
